In the most recent December quarter, there were 19 IPOs worth US $ 1,836 million, the largest of which was that of Gland Pharma, which has an issue size of US $ 869 million. There were only 11 IPOs in the year-ago quarter.
According to the report, India is ranked 9th in the world in terms of IPOs in 2020, with 43 IPOs raising US $ 4.09 billion.
“The IPO market has strong momentum, and there is growing interest from companies across the sector looking to raise funds in the short term. In addition, companies are waiting for guidelines for direct listing on foreign markets. Sentiment remains positive, as it could become a star 2021. ” Sandip Ketan, Partners and National Leaders, Financial Accounting Advisory Services (FAAS)so EY India,Said.
During the December 2020 quarter, the IPOs for key markets were 10, compared to 5 in the year-ago quarter.
According to the report, real estate, hospitality, construction and various industrial products are the most active sectors (in terms of IPO numbers), and three IPOs have been launched in each sector (including major markets and SME markets). It was.
According to the report, global IPO volume continued to accelerate in 2020, rising 19% to 1,363 and revenues up 29% year-on-year to a total of US $ 268 billion.
Last year, IPO activity proved resilient to the effects of the COVID-19 pandemic, backed by low interest rates and expanding monetary policy.
“Despite the difficult years, activity in 2020 in the Asia Pacific region exceeded 2019, with 2020 sales up 20% (822) and revenue up 45% (US $ 136.2 billion).
“In fact, the region has been the most profitable since 2010. Industrial has generated $ 20.8 billion in 181 IPOs, technology has generated $ 180 and $ 38.7 billion in IPOs, and 95 IPOs in materials. Raised US $ 7.4. Billion, “said the report.
Gland Pharma’s $ 1.84 billion IPO, 18 other companies launch from October to December
https://economictimes.indiatimes.com/markets/stocks/news/india-sees-19-ipos-worth-1-84-billion-in-2020-december-quarter/articleshow/80434486.cms Gland Pharma’s $ 1.84 billion IPO, 18 other companies launch from October to December